Valuation: EMV Capital plc

Market Cap 12.73M 17.11M 14.83M 14.02M 23.85M 1.64B 23.99M 167M 64.66M 833M 64.28M 62.86M 2.65B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 17M 22.86M 19.81M 18.72M 31.86M 2.19B 32.05M 224M 86.37M 1.11B 85.87M 83.96M 3.55B EV / Sales 2026 *
5.26x
EV / Sales 2027 * 4.93x
Free-Float
52.51%
Yield 2026 *
-
Yield 2027 * -
1 week-4.81%
Current month-9.90%
1 month-14.95%
3 months-7.14%
6 months-17.27%
Current year-20.18%
1 week 44.7
Extreme 44.7
48
1 month 44.7
Extreme 44.7
55
Current year 44
Extreme 44
62
1 year 40.25
Extreme 40.25
62
3 years 34
Extreme 34
80.5
5 years 34
Extreme 34
137
10 years 9.75
Extreme 9.75
846
Manager TitleAgeSince
Chief Executive Officer 50 01/05/2020
Director of Finance/CFO 45 01/12/2025
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 50 14/10/2019
Director/Board Member 47 09/12/2022
Chairman 61 01/02/2023
Date Insider Type Main position Quantity % Market Cap. Importance
08/01/26 Buy 7,000 0.0250%
08/01/26 Sell 7,000 0.0250%
19/12/25 Buy

Director

34,484 0.1242%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.81%+8.33%-26.02% 17.16M
-0.19%-3.90%+46.67%+17.23% 3.49B
-1.02%-0.51%-8.37%+6.38% 3.26B
-1.68%+1.08%+33.69%+29.84% 1.93B
+3.44%-2.50%+89.25%+171.09% 1.36B
0.00%0.00%-1.72%-7.02% 727M
+2.37%+4.59%+123.13%+228.66% 625M
0.00%0.00%-3.97%-7.05% 408M
0.00%0.00%-28.57%-73.08% 389M
0.00%0.00%-0.53%-13.02% 369M
Average +0.26%-1.48%+25.79%+32.70% 1.26B
Weighted average by Cap. -0.13%-1.44%+30.63%+37.62%

Financials

2026 *2027 *
Net sales 3.23M 4.34M 3.76M 3.56M 6.05M 417M 6.09M 42.47M 16.41M 211M 16.31M 15.95M 674M 3.33M 4.48M 3.88M 3.67M 6.25M 430M 6.28M 43.82M 16.93M 218M 16.83M 16.46M 695M
Net income - -
Net Debt 4.27M 5.75M 4.98M 4.71M 8.01M 551M 8.05M 56.18M 21.71M 280M 21.58M 21.1M 891M 3.71M 4.99M 4.32M 4.08M 6.95M 478M 6.99M 48.75M 18.84M 243M 18.73M 18.31M 773M
Logo EMV Capital plc
EMV Capital plc is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It focuses on generating returns for investors from the sectors and technologies. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its portfolio includes AMR Bio, Wanda Health, Deeptech Recycling Technologies, EpiBone, Sofant Technologies, Q-Bot, and others. Its portfolio, Glycotest, is a liver disease diagnostics company commercializing novel and unique blood tests for life-threatening liver cancers and fibrosis-cirrhosis. ProAxsis Limited is a commercial biomarker-led research company supporting drug development and clinical research through specialist biomarker insights.
Employees
21
Date Price Change Volume
16/09/26 GBX 45.50 0.00% 1,801
15/09/26 GBX 45.50 -3.19% 4,486
14/09/26 GBX 47.00 0.00% 69,965
11/09/26 GBX 47.00 -1.67% 19,434
10/09/26 GBX 47.80 0.00% 3,068
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.4550GBP
Average target price
1.320GBP
Spread / Average Target
+190.11%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMVC Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!